AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2025

Nov 7, 2025

33090_dirs_2025-11-07_090b2d6e-d8db-46ea-a1ea-f1d76ed015c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2025-10-01

Reporting Person: D'Silva Andrew J. (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-01	Common Stock	F	414	$18.98	Disposed	47100	Direct
2025-10-03	Common Stock	F	794	$18.75	Disposed	46306	Direct

Footnotes

F1: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.